WDA
CVS icon

Wendell David Associates’s CVS Health CVS Stock Holding History

Wendell David Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,423
Closed -$261K – 161
2024
Q2 		$261K Sell
4,423
-985
-18% -$61.6K 0.03% 146
2024
Q1 		$431K Sell
5,408
-356
-6% -$27.2K 0.04% 122
2023
Q4 		$455K Sell
5,764
-2,500
-30% -$178K 0.05% 120
2023
Q3 		$577K Sell
8,264
-1,800
-18% -$128K 0.07% 99
2023
Q2 		$696K Hold
10,064
– – 0.08% 98
2023
Q1 		$748K Hold
10,064
– – 0.09% 95
2022
Q4 		$938K Hold
10,064
– – 0.12% 90
2022
Q3 		$960K Hold
10,064
– – 0.13% 85
2022
Q2 		$933K Hold
10,064
– – 0.12% 90
2022
Q1 		$1.02M Hold
10,064
– – 0.11% 87
2021
Q4 		$1.04M Hold
10,064
– – 0.11% 90
2021
Q3 		$854K Hold
10,064
– – 0.1% 96
2021
Q2 		$840K Buy
10,064
+1,170
+13% +$95.8K 0.09% 96
2021
Q1 		$669K Sell
8,894
-17
-0.2% -$1.24K 0.08% 100
2020
Q4 		$609K Sell
8,911
-1,143
-11% -$74.3K 0.07% 102
2020
Q3 		$587K Hold
10,054
– – 0.08% 98
2020
Q2 		$653K Buy
10,054
+419
+4% +$26.4K 0.09% 98
2020
Q1 		$572K Hold
9,635
– – 0.1% 95
2019
Q4 		$716K Sell
9,635
-200
-2% -$14K 0.1% 100
2019
Q3 		$620K Hold
9,835
– – 0.09% 103
2019
Q2 		$536K Sell
9,835
-2,147
-18% -$116K 0.08% 109
2019
Q1 		$646K Sell
11,982
-4,700
-28% -$290K 0.1% 103
2018
Q4 		$1.09M Buy
16,682
+1,022
+7% +$76.3K 0.2% 87
2018
Q3 		$1.23M Sell
15,660
-590
-4% -$42.2K 0.19% 89
2018
Q2 		$1.05M Sell
16,250
-112
-0.7% -$7.38K 0.18% 92
2018
Q1 		$1.02M Sell
16,362
-1,038
-6% -$74.5K 0.18% 93
2017
Q4 		$1.26M Sell
17,400
-7,600
-30% -$553K 0.22% 88
2017
Q3 		$2.03M Sell
25,000
-6,915
-22% -$547K 0.36% 73
2017
Q2 		$2.57M Sell
31,915
-2,450
-7% -$193K 0.48% 51
2017
Q1 		$2.7M Sell
34,365
-500
-1% -$39.9K 0.52% 50
2016
Q4 		$2.75M Sell
34,865
-3,335
-9% -$270K 0.54% 53
2016
Q3 		$3.4M Buy
38,200
+2,285
+6% +$216K 0.67% 43
2016
Q2 		$3.45M Buy
35,915
+2,505
+7% +$250K 0.68% 45
2016
Q1 		$3.48M Buy
33,410
+3,450
+12% +$335K 0.67% 43
2015
Q4 		$2.94M Buy
29,960
+3,735
+14% +$366K 0.58% 46
2015
Q3 		$2.52M Buy
26,225
+6,150
+31% +$647K 0.52% 49
2015
Q2 		$2.11M Buy
20,075
+100
+0.5% +$10.2K 0.41% 65
2015
Q1 		$2.06M Buy
19,975
+25
+0.1% +$2.53K 0.4% 67
2014
Q4 		$1.92M Sell
19,950
-925
-4% -$81.5K 0.37% 66
2014
Q3 		$1.67M Hold
20,875
– – 0.35% 67
2014
Q2 		$1.57M Hold
20,875
– – 0.33% 70
2014
Q1 		$1.57M Hold
20,875
– – 0.34% 67
2013
Q4 		$1.5M Buy
20,875
+240
+1% +$15.4K 0.33% 66
2013
Q3 		$1.18M Buy
20,635
+1,000
+5% +$59.6K 0.28% 71
2013
Q2 		$1.12M Buy
+19,635
New +$1.14M 0.28% 71

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Wendell David Associates's CVS Position: Q3 2024 in Review

Wendell David Associates sold out of CVS Health (CVS) in Q3 2024, closing a stake of 4,423 shares — an estimated $261K sold.

Wendell David Associates first reported a position in CVS in Q2 2013 and held it in 45 quarters. The position peaked at $3.48M in Q1 2016. 1,841 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • Wendell David Associates reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
  • Wendell David Associates sold 4,423 CVS Health shares in Q3 2024, an estimated $261K.
  • Wendell David Associates first reported a position in CVS Health in Q2 2013 and held it in 45 quarters.
  • Wendell David Associates's CVS Health position peaked at $3.48M in Q1 2016.
  • 1,841 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Wendell David Associates's 13F filing for Q3 2024, filed 21 Oct 2024.